Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Home
Tags
Pfizer
Tag: Pfizer
New Approach to Address the Unmet Medical Need in the Early...
Peter Hofland, Ph.D
-
November 13, 2020
Nivolumab + ipilimumab Shows Continued Survival in Patients with Metastatic Renal...
Peter Hofland, Ph.D
-
February 15, 2020
ESMO 2019: Seattle Genetics to Present Latest Study Data – Becomes...
Peter Hofland, Ph.D
-
September 17, 2019
Europe Adopts Pembrolizumab + Axitinib as First-Line Treatment for Advanced Renal...
Peter Hofland, Ph.D
-
July 29, 2019
FDA Approves Pfizer’s Biosimilar rituximab-pvvr for Certain Cancers and Autoimmune Conditions
Peter Hofland, Ph.D
-
July 24, 2019
Pfizer to Showcase Data from Innovative Science at 2019 Annual ASCO...
Peter Hofland, Ph.D
-
May 17, 2019
Daiichi Sankyo to Colaborate with Merck KGaA and Pfizer in Development...
Peter Hofland, Ph.D
-
October 25, 2018
FDA Accepts New Drug Application for Pfizer?s Third-Generation ALK Inhibitor Lorlatinib
Sonia Portillo
-
February 12, 2018
New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer
Peter Hofland, Ph.D
-
February 10, 2018
Dacomitinib may Offer New Treatment Option for Patients with EGFR-Positive Lung...
Peter Hofland, Ph.D
-
June 6, 2017
1
2
Page 1 of 2
LATEST NEWS
Mount Sinai Researchers Awarded Grant to Explore Therapeutic Approach to KRAS-Mutant Lung Tumors
Editorial Team
-
August 9, 2022
Osimertinib + Savolitinib Demonstrated 49% ORR in Lung Cancer Patients with MET Over-expression
Editorial Team
-
August 9, 2022
Tarlatamab Shows Encouraging Anti-tumor Activity Against SCLC in Phase 1 Trial
Editorial Team
-
August 9, 2022
Scientists Identify a Molecular Biomarker for Cancer that Ventures Off to Form Distant Tumors
Editorial Team
-
August 8, 2022
Simple Blood Test Could Lead to Better Detection of Glioblastoma
Editorial Team
-
August 2, 2022
X